PORTFOLIO NEWS Jigar Raythatha Rejoins Constellation Pharmaceuticals as President and CEO May 25, 2017 Read More » Surrozen Launches Into Regenerative Medicine With $33 Million in Series A Financing Led by The Column Group February 15, 2017 Read More » Tenaya Therapeutics Launches with the Goal of Curing Heart Disease December 6, 2016 Read More » Arcus Aims to Build an Immuno-Oncology Powerhouse to Offer a Rational Approach to Combination Therapy September 19, 2016 Read More » Kallyope Inc. Launches with $44m Series A Financing to Harness the Potential of the Gut-Brain Axis December 10, 2015 Read More » Gritstone Oncology Announces $102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies October 20, 2015 Read More » Seragon Highlighted in Genentech’s “The Value of the Right Partner” June 12, 2015 Read More » Constellation Pharmaceuticals Initiates Clinical Development of CPI-1205, a Novel Inhibitor of EZH2, in Patients with Lymphoma April 28, 2015 Read More » Flexus Biosciences Announces Closing of its Acquisition by Bristol-Myers Squibb April 8, 2015 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Next »
Surrozen Launches Into Regenerative Medicine With $33 Million in Series A Financing Led by The Column Group February 15, 2017 Read More »
Arcus Aims to Build an Immuno-Oncology Powerhouse to Offer a Rational Approach to Combination Therapy September 19, 2016 Read More »
Kallyope Inc. Launches with $44m Series A Financing to Harness the Potential of the Gut-Brain Axis December 10, 2015 Read More »
Gritstone Oncology Announces $102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies October 20, 2015 Read More »
Constellation Pharmaceuticals Initiates Clinical Development of CPI-1205, a Novel Inhibitor of EZH2, in Patients with Lymphoma April 28, 2015 Read More »
Flexus Biosciences Announces Closing of its Acquisition by Bristol-Myers Squibb April 8, 2015 Read More »
